Abstract
Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Central Nervous System Agents in Medicinal Chemistry
Title: Regulatory T Cells in Central Nervous System: in Health and Disease
Volume: 10 Issue: 4
Author(s): Brenda Saenz, Jesus Perez-H and Anahi Chavarria
Affiliation:
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Abstract: Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Export Options
About this article
Cite this article as:
Saenz Brenda, Perez-H Jesus and Chavarria Anahi, Regulatory T Cells in Central Nervous System: in Health and Disease, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (4) . https://dx.doi.org/10.2174/187152410793429674
DOI https://dx.doi.org/10.2174/187152410793429674 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches
Current Medical Imaging Identification of Tumor Targeting Agents by Phage Display
Medicinal Chemistry Reviews - Online (Discontinued) Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
Current Neuropharmacology Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs as Cancer Biomarkers
MicroRNA Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities - a Review
Current Pharmaceutical Design Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells
Current Radiopharmaceuticals Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Recent Advances in Delivery Through the Blood-Brain Barrier
Current Topics in Medicinal Chemistry Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Molecular Markers of Glioblastoma and the Potential for Integration with Imaging: the Future for Assigning Prognosis and Best Treatment Strategy
Current Molecular Imaging (Discontinued) Radiation-Induced Stress Proteins - the Role of Heat Shock Proteins (HSP) in Anti- Tumor Responses
Current Medicinal Chemistry Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design Neurovascular Signals Suggest a Propagation Mechanism for Endogenous Stem Cell Activation Along Blood Vessels
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry Connecting Parkinsons Disease and Drug Addiction: Common Players Reveal Unexpected Disease Connections and Novel Therapeutic Approaches
Current Pharmaceutical Design